Session Details

F083 Journal Watching

Mon, Mar 22, 1:00 PM - 3:00 PM
2 CME Available Forum

DESCRIPTION

The Journal Watching forum reviews the literature of the past year to digest and summarize the highest impact articles to save you time and keep you up to date. Experts from across the country come together for a session that is high yield, showcasing advances in Melanoma research, Dermatopathology, Surgical Dermatology, Cosmetic Dermatology, Medical and Pediatric Dermatology. Bring your questions, there will be time at the end for discussion.

LEARNING OBJECTIVES

1.

Recognize advances in the diagnosis and/or management of melanoma.

2.

Describe the latest discoveries in MOHS & dermatologic surgery.

3.

Identify current innovations in medical and pediatric dermatology.

SCHEDULE

1:00 PM

Introduction

Mary Wu Chang, MD, FAAD

1:03 PM

Medical Dermatology Update

Akua P. Sarfo, PhD, MD, FAAD

1:20 PM

Melanoma Update

Sameer Gupta, MD, FAAD

1:37 PM

Moh's Surgery: What is New?

Murad Alam, MD, MSCI, MBA, FAAD

1:54 PM

Pediatric Dermatology News You Can Use

Mary Wu Chang, MD, FAAD

2:11 PM

Dermatopathology Focus

Kenneth Y. Tsai, MD, PhD, FAAD

2:28 PM

Cosmetic Dermatology: What's Hot

Sandy Sharon Tsao, MD, FAAD

2:45 PM

Q & A

DIRECTOR

Mary Wu Chang, MD, FAAD

Mary Wu Chang, MD, FAAD

University of Connecticut

SPEAKERS

Sameer Gupta, MD, FAAD

Sameer Gupta, MD, FAAD

Akua P. Sarfo, PhD, MD, FAAD

Akua P. Sarfo, PhD, MD, FAAD

Kenneth Y. Tsai, MD, PhD, FAAD

Kenneth Y. Tsai, MD, PhD, FAAD

H. Lee Moffitt Cancer Center & Research Institute

DISCLOSURES

Mary Wu Chang, MD, FAAD

Wiley & Sons, Inc. – Other(Honoraria);

Sameer Gupta, MD, FAAD

No financial relationships exist with ineligible companies.

Akua P. Sarfo, PhD, MD, FAAD

No financial relationships exist with ineligible companies.

Kenneth Y. Tsai, MD, PhD, FAAD

3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); Ankyra Therapeutics – Independent Contractor(Grants/Research Funding); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);